search
AI laboratories
Trends
- 1Insilico Medicine signs multimillion AI drug discovery deal●Insilico Medicine strikes tens-of-millions AI co-development deal with unnamed foundation-model lab
Insilico Medicine, the Hong Kong-based clinical-stage biotech known for using generative AI in drug discovery, has struck a co-development deal worth tens of millions of dollars with an unnamed foundation-model laboratory. The partnership will focus on building AI models for drug development. The identity of the partner lab has not been disclosed.
- 2
Anthropic has established its own wet laboratory as the company expands its AI drug discovery program, according to a Reuters report. The move signals the AI firm's growing ambition to apply its models to hands-on biological research, not just software. Observers see it as a notable step in the convergence of artificial intelligence and pharmaceutical development.
- 3Anthropic says its biology lab has found something big●Anthropic says it's bio lab has found something big
Anthropic reports that its internal biology laboratory has made a significant discovery, teasing the finding as "something big" without yet revealing details. The announcement is drawing attention across the tech and science communities, with observers speculating about what an AI company's bio lab could have uncovered and what it means for AI-driven research.
- 4AI helping scientists advance biological design in health research●How AI is allowing scientists to advance biological design for health research: HealthLink
Scientists are increasingly using artificial intelligence to speed up biological design for health research, applying AI tools to engineer proteins, model biological systems and accelerate drug and therapy development. The approach is being highlighted as a way to cut research timelines and expand what laboratories can design, with health reporters examining how the technology is changing biomedical science and what it could mean for future treatments.